Rutin ameliorates obesity through brown fat activation

Area of Science:

• Metabolic disorders
• Obesity and diabetes treatment
• Brown adipose tissue (BAT) activation

Background:

• Increasing energy expenditure via BAT activation is key for treating obesity and diabetes.
• Rutin is a clinically used, safe natural compound with potential metabolic benefits.
• Obesity and associated metabolic disorders remain significant global health challenges.

Purpose of the Study:

• To investigate rutin's effect on whole-body energy metabolism by enhancing BAT activity.
• To determine if rutin can ameliorate obesity and improve glucose homeostasis.
• To elucidate the molecular mechanisms underlying rutin's action on BAT.

Main Methods:

• Administration of rutin to genetically obese (Db/Db) and diet-induced obesity (DIO) mice.
• Assessment of adiposity, energy expenditure, and glucose homeostasis.
• Analysis of brown-like adipocyte (beige) formation and molecular pathways involving SIRT1, PGC-1α, and UCP1 in BAT.

Main Results:

• Rutin treatment significantly reduced adiposity and increased energy expenditure in both obesity models.
• Rutin improved glucose homeostasis and induced beige adipocyte formation.
• Rutin stabilized SIRT1, leading to PGC-1α hypoacetylation, enhanced Tfam transactivation, and increased mitochondrial activity and UCP1 levels in BAT.

Conclusions:

• Rutin activates brown adipose tissue (BAT) and ameliorates obesity and related metabolic dysfunction.
• Rutin's mechanism involves direct binding and stabilization of SIRT1, impacting key metabolic regulators.
• Rutin represents a novel therapeutic candidate for treating metabolic disorders like obesity and diabetes.